Traumatic Brain Injury (TBI) Clinical Trial
Official title:
Novel Regenerative Therapeutic in Chronic Complex TBI
This study will determine if allopregnanolone (ALLO) improves depression and pain symptoms in patients who have a history of mild traumatic brain injury (TBI) [primary endpoints]. The investigators will also determine if ALLO improves functional outcome [secondary endpoint]. Participants in this study will receive an intravenous infusion of either ALLO or placebo. Behavioral assessments will be conducted during the infusion and at several time points post-infusion.
ALLO is a neurosteroid that exhibits multiple actions highly relevant to the treatment of chronic complex TBI. The investigators' recent human data suggest that ALLO is decreased in patients with TBI, suggesting that ameliorating deficits of this neurosteroid may be clinically therapeutic. In addition, multiple groups have reported ALLO reductions in patients with conditions that frequently co-occur with TBI, including depression and pain disorders. 132 Veterans with a history of mild TBI with co-occurring depression and pain symptoms (chronic complex TBI) will be randomized to either intravenous placebo or ALLO (3 groups/44 participants per group: placebo, lower dose ALLO, higher dose ALLO). Following a loading dose, Veterans will receive placebo or ALLO infusion targeted to achieve serum ALLO levels of 0 nM (placebo), 50 nM (ALLO lower dose), or 150nM (ALLO higher dose). Behavioral assessments will be conducted during the infusion, post-taper, and 24 hours post-infusion. In addition, the investigators will conduct behavioral assessments 7 days and 14 days post-infusion. The investigators hypothesize that ALLO will be well-tolerated in patients with complex TBI, and that this intervention may reduce depression and pain symptoms (in addition to potentially improving function). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02878577 -
Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury
|
||
Active, not recruiting |
NCT02918994 -
LearningRx Cognitive Training for TBI
|
N/A | |
Completed |
NCT02524067 -
Modified Environment for Agitation in Patients With TBI
|
N/A | |
Completed |
NCT01760785 -
Valproate for Mood Swings and Alcohol Use Following Head Injury
|
N/A | |
Recruiting |
NCT05033444 -
A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01750268 -
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
|
Phase 4 | |
Recruiting |
NCT01512524 -
Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury
|
N/A | |
Completed |
NCT04796207 -
The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes
|
N/A | |
Completed |
NCT02657135 -
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
|
N/A | |
Completed |
NCT01956136 -
Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury
|
N/A | |
Withdrawn |
NCT02356861 -
LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans
|
N/A | |
Recruiting |
NCT04930146 -
Functional Recovery Effect of Bloodletting Puncture at Jing-well Points on Acute Brain Injury Patients
|
N/A | |
Not yet recruiting |
NCT05675423 -
Imaging Characterization of the Biomechanical Coupling of Brain and Skull
|
||
Withdrawn |
NCT01891383 -
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
|
||
Withdrawn |
NCT01779427 -
Attention Intervention Management
|
N/A | |
Completed |
NCT02764983 -
Occupational Therapy Driving Intervention for Returning Combat Veterans.
|
N/A | |
Completed |
NCT01118195 -
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
|
N/A | |
Completed |
NCT01547780 -
Translocator Protein and Inflammation After Traumatic Brain Injury
|
Phase 1/Phase 2 | |
Recruiting |
NCT03874208 -
Prediction for Coma Recovery With Comaweb
|
N/A | |
Completed |
NCT03314584 -
Managing MTBI-related Headaches With rTMS
|
N/A |